Category1 Category2 Category3

The Government of India intends to block the acquisition by China's drug company Shanghai Fosun Pharmaceutical (Fosun Pharma) of the Indian pharmaceutical company Gland Pharma for $1.4 billion, according to Russia's Pharmatsevtichesky Vestnik (Pharmaceutical Bulletin). 

ID:5P5F-C4D1-F165-Y463_0